Advent Technologies
NASDAQ:ADNAdvent Technologies Holdings, Inc., an advanced materials and technology development company, operates in the fuel cell and hydrogen technology markets in North America, Europe, and Asia. It develops, manufactures, and assembles fuel cell systems and critical components that determine the performance of hydrogen fuel cells and other energy systems. The company offers high-temperature proton exchange membrane (HT-PEM) fuel cells, including membrane electrode assemblies, bipolar plates, and reformers, as well as provides fuel-cell stack assembly and testing services. It serves stationary power, portable power, automotive, aviation, energy storage, and sensor markets. The company is headquartered in Boston, Massachusetts.
Aurania Resources
CVE:ARUAurania Resources Ltd., a junior exploration mining company, engages in the identification, evaluation, acquisition, and exploration of mineral properties in Ecuador and Peru. The company explores for gold, silver, copper, and other precious metal deposits. Its flagship project is the 100% owned Lost Cities Cutucu project comprises 42 mineral exploration concessions covering an area of approximately 207,764 hectares located in southeastern Ecuador. The company was formerly known as Urania Resources Ltd. and changed its name to Aurania Resources Ltd. in March 2012. Aurania Resources Ltd. was founded in 2001 and is headquartered in Toronto, Canada.
Mylan
NASDAQ:MYLMylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded-generic, brand-name, and over-the-counter (OTC) pharmaceutical products in North America, Europe, and internationally. It offers active pharmaceutical ingredients and finished dosage forms; and antiretroviral medicines to treat HIV/AIDS. The company also provides prescription products, such as EpiPen Auto-Injector; Perforomist Inhalation Solution; Dymista; Creon; and Influvac, as well as YUPELRI, an inhalation solution for the maintenance treatment of patients with chronic obstructive pulmonary diseases. In addition, it markets OTC products, including Cold-EEZE, MidNite, Vivarin, Brufen, CB12, and EndWarts. The company offers its products to therapeutic areas, such as cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, gastroenterology, immunology, infectious disease, oncology, respiratory and allergy, and women's health. Its customers include retail pharmacies, wholesalers and distributors, payers, and insurers and governments, as well as institutions, such as hospitals. Mylan N.V. has collaboration and license agreements with Pfizer Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; Fujifilm Kyowa Kirin Biologics Co. Ltd; and Revance Therapeutics, Inc. The company was founded in 1961 and is based in Hatfield, the United Kingdom.
Troilus Gold
CVE:TLGTroilus Gold Corp., a development-stage mineral exploration company, explores for and develops mineral properties in Canada. The company primarily explores for gold and copper deposits. It owns 100% interest in the Troilus project covering an area of 4,718.6 ha located to the northwest of the Val-d'Or district in Quebec. Troilus Gold Corp. is headquartered in Toronto, Canada.